CONTROLLED LIBERATION PHARMACEUTICAL PREPARATIONS IN THE FORM OF MULTIPLE UNITS INDEPENDENT FROM THE SHAKING AND PROCESS FOR PREPARING THE SAME

摘要

The present invention relates to orally administrable multiple-unit sustained-release dose forms having controlled agitation-independent release of active compound and processes for their production using a selected erodable hydrophilic polymer (HPC) and a limitation of the maximum size of the active compound-containing polymer particles to =3 MM.